IR Biosciences Holdings, Inc.
IRBS
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | |
|---|---|---|---|---|---|
| Net Income | 18.33% | 52.61% | 43.54% | -13.72% | -11.29% |
| Total Depreciation and Amortization | -39.42% | 114.65% | 134.31% | -41.44% | -17.47% |
| Total Amortization of Deferred Charges | -4.02% | -7.26% | 58.72% | 134.41% | 394.32% |
| Total Other Non-Cash Items | -20.53% | -78.75% | -70.76% | 122.99% | 218.83% |
| Change in Net Operating Assets | 2,377.11% | 3,059.33% | 356.53% | 200.35% | 69.64% |
| Cash from Operations | 85.04% | 76.89% | 65.68% | 49.13% | 39.70% |
| Capital Expenditure | -- | 100.00% | 100.00% | 100.00% | 92.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 100.00% | 100.00% | 92.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.26% | 77.61% | -323.26% | -245.68% | -197.98% |